Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Friesland Campina Ingredients North America
EIR
•Friesland Campina Ingredients North America•June 13, 2019

Friesland Campina Ingredients North America – FDA EIR, Jun 13, 2019

Record Details

The FDA conducted an inspection of Friesland Campina Ingredients North America's facility in Delhi, NY, on June 13, 2019. This inspection, carried out under the HAFE1 FY19 High Risk workplan and guided by the Compliance Program Guidance Manual 7303.803 (Domestic Food Safety) and DFPG #19-03 (Current Good Manufacturing Practices, Hazard Analysis, and Risk-Based Preventive Controls in Human Foods Inspections), focused on the company's production of Hyvital Whey Easy to Digest 100, an ingredient for infant formula. The firm is required to develop and maintain a written food safety plan. The inspection encompassed a review of the firm's food safety plan, risk assessments, procedures, environmental monitoring, complaint handling, and recall processes. A thorough walk-through was also conducted to observe the manufacturing process for ETD 100. Critically, the inspection revealed no significant deficiencies or issues. The company's operations and documentation, including its Critical Control Point for pathogen elimination and complaint management, were found to be satisfactory. As a result, no FDA 483 (Inspectional Observations) was issued, and no samples were collected. The report concluded without identifying any specific violations or requiring any mandatory actions from the company, indicating a compliant status at the time of the inspection.

Company
Friesland Campina Ingredients North America
Inspection date
June 13, 2019
Product type
other
Office
Division of Human and Animal Food Operations - East I
People
  • Terri L. Theobald (recipient)
  • Quentin Ford (company_representative)
  • Elbia Galo (company_representative)
  • Robert J. Veitch (investigator)
  • Martin Ansing (recipient)
View Company Profile

ID · 1cd283d3-bd83-4bea-907e-7bee9d4cf95f

Violation Codes1
21 CFR 820.198

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Friesland Campina Ingredients North America
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.